Pfizer said on Friday it could file for U.S. authorization of the COVID-19 vaccine it is developing with German partner BioNTech as early as late November, suggesting that it's possible a vaccine could be available in the United States this year, but that timeline makes it unlikely a vaccine will be available before the U.S. election as President Donald Trump has promised.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook